Hims & Hers stock rises nearly 4% as oversold conditions spark intraday recovery

Traders Union
All News
Stocks
Hims & hers rises 3.65% today

Highlights

Shares of Hims & Hers are trading below short- and medium-term moving averages but remain above long-term support levels.
Technical momentum is strongly bearish with indicators pointing to weak directional strength and oversold conditions.
Expected five-day range is $27.45 to $29.26, with over 80% probability of a downward move and sideways consolidation baseline.

Anton Kharitonov, expert at Traders Union, notes that Hims & Hers Health Inc faces a muted rebound. Technical signals show the stock remains weak, with both short- and medium-term momentum negative and the price stuck under key moving averages. He observes that there is no meaningful news to support bullish sentiment, so market confidence appears fragile. Oscillator readings reinforce the possibility of further selling and limited upside. Kharitonov concludes, "Persistent seller control and weak technicals mean short-term rallies in HIMS should be treated with caution."

Viktoras Karapetjanc, expert at Traders Union, sees opportunity in HIMS despite near-term volatility. He highlights that above-average volatility coupled with strong 200-day support ensures the bullish structure remains intact for long-term investors. Karapetjanc believes that sustained consolidation above $28.23 keeps further recovery in play, with macro stability and technical resilience supporting this view. "A close above $29.26 could unlock the next upward leg, so I remain optimistic about HIMS’s continued growth prospects," he says.

Sholanke Dele, market strategist, views HIMS’s rebound as tenuous. He points out the lack of news or positive macro drivers leaves the stock exposed to broader risk-off sentiment. Downside probability remains high, especially if key support is broken. "Market volatility looks set to weigh on HIMS, and without fresh catalysts, the downside risk persists," Dele warns.

Long-term support contrasts with persistent short-term bearish momentum

Hims & Hers is trading below its 20-day and 50-day moving averages ($29.36 and $31.04), but remains above the 200-day moving average ($28.23), indicating persistent long-term support amid pressured short- and medium-term momentum. The near-term ceiling is at $29.26 and support sits at $28.31. Broader technical alignment remains bullish, as signaled by the distant 200-day moving average and Ichimoku Kijun ($30.56), though these are not shaping current price action. Momentum gauges remain bearish: MACD and RSI still flag sell signals, ADX highlights weak direction, and oscillators including the Stochastic RSI, CCI, BBP, and Awesome Oscillator all tilt negative, reflecting seller dominance and an oversold setup. While HIMS is rebounding near session highs with above-average volatility, downside momentum remains pronounced overall.

Earlier, analysts noted that Hims & Hers Health faced persistent technical resistance and regulatory risks, leading to a generally cautious outlook. The latest price action reinforces this stance as any sustainable upside will hinge on a decisive break above $29.26, while a drop below $27.45 could trigger renewed selling pressure in the days ahead.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.